Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.
AUTOR(ES)
Warny, M
RESUMO
This study investigated whether differences in fecal and serum antitoxin A antibody levels may account for the duration of Clostridium difficile-associated diarrhea (CDAD) and the occurrence of relapses. By an enzyme linked-immunosorbent assay, we tested 40 patients with CDAD including 25 patients without immunodeficiency and 15 patients receiving antineoplastic drugs. Two hundred eighty serum samples and 80 normal stool samples were investigated as controls. In nonimmunocompromised patients, serum immunoglobulin (IgG) and fecal IgA antitoxin A antibody titers were significantly higher in patients who suffered a single episode (n = 21) than in those with relapsing CDAD (n = 4) whose titers were at control levels. Of these 25 patients, eight suffered from diarrhea which lasted for more than 2 weeks. These patients had significantly lower serum- and feces-specific antibody levels than the others who presented symptoms of shorter duration. In cytostatic-treated patients, antitoxin A antibody levels were similar to controls, but relapses occurred in a single case. These data suggest an association between a defective humoral response to toxin A and a more severe form of C. difficile infection. They also indicate that other host-related factors control the severity of CDAD and remain to be elucidated.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=186119Documentos Relacionados
- Clostridium difficile Vaccine and Serum Immunoglobulin G Antibody Response to Toxin A
- Cytokine response by human monocytes to Clostridium difficile toxin A and toxin B.
- Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes.
- Human antibody response to outer membrane proteins of Campylobacter jejuni during infection.
- Toxin Gene Analysis of a Variant Strain of Clostridium difficile That Causes Human Clinical Disease